Fredag 20 Mars | 20:12:16 Europe / Stockholm

Kalender

Est. tid*
2026-08-28 N/A Kvartalsrapport 2026-Q2
2026-04-09 N/A X-dag ordinarie utdelning MONSO 0.00 DKK
2026-04-08 N/A Årsstämma
2026-03-05 - Bokslutskommuniké 2025
2025-08-29 - Kvartalsrapport 2025-Q2
2025-04-11 - X-dag ordinarie utdelning MONSO 0.00 DKK
2025-04-10 - Årsstämma
2025-03-07 - Bokslutskommuniké 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-04-29 - Årsstämma
2024-04-11 - X-dag ordinarie utdelning MONSO 0.00 DKK
2024-03-06 - Bokslutskommuniké 2023
2023-09-07 - Kvartalsrapport 2023-Q2
2023-04-13 - X-dag ordinarie utdelning MONSO 0.00 DKK
2023-04-12 - Årsstämma
2023-03-08 - Bokslutskommuniké 2022
2022-12-20 - Extra Bolagsstämma 2022
2022-08-31 - Kvartalsrapport 2022-Q2
2022-04-07 - X-dag ordinarie utdelning MONSO 0.00 DKK
2022-04-06 - Årsstämma
2022-03-09 - Bokslutskommuniké 2021
2021-11-16 - Extra Bolagsstämma 2021
2021-08-26 - Kvartalsrapport 2021-Q2
2021-04-15 - X-dag ordinarie utdelning MONSO 0.00 DKK
2021-04-14 - Årsstämma
2021-03-10 - Bokslutskommuniké 2020

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorInformationsteknik
IndustriProgramvara
Monsenso är verksamt inom IT-sektorn. Bolaget är specialiserat inom digitala uppföljningssystem för vård och omsorg, samt sjukhus. Lösningarna är mjukvarubaserade och används huvudsakligen för uppföljning av patienters hälsotillstånd, samt för intern bevakning och analys. Störst verksamhet återfinns inom den nordiska marknaden. Huvudkontoret ligger i Köpenhamn.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-03-20 11:54:40

20.3.2026 11:54:38 CET | Monsenso | Inside information

Company Announcement no. 02-2026

Copenhagen, 2026.03.19

This message includes inside information

In our 2025 annual report (note 2), we mentioned that negotiation of an order was in the final stage. That order has now been signed. It does not change our revenue expectations for 2026, but it reduces the financial risks we mentioned. We also plan to raise additional capital in the second quarter of 2026.

As part of the agreement, Monsenso is configuring and delivering its digital health platform for an international, private healthcare provider. The platform will be used to collect patient-reported data, support medication adjustments, provide patients with information about their treatment and medication, facilitate communication between patients and healthcare providers, and deliver more personalised remote care.

“The potential of this agreement is significant. It includes an initial order to set up and configure the platform, and it will bring in recurring revenue in the future. There is also strong potential to expand into other disease areas already covered by the customer” says Thomas Lethenborg, CEO of Monsenso.

Further information:

Monsenso

CEO
Thomas Lethenborg
Tel. +45 21 29 88 27
E-mail: lethenborg@monsenso.com 

Chairman of the board
Peter Mørch Eriksen
E-mail: Petermorcheriksen@outlook.com

Certified Adviser:

HC Andersen Capital
Bredgade 23, 
1260 København  

About Monsenso

Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence and behavioral data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. We collaborate with health and social care, pharmaceuticals and leading researcher worldwide in our endeavors to deliver solutions that fit into the lives of patients and health care professionals. To learn more visit www.monsenso.com

Attachments

Original release